Leaders emphasized a life-chain approach prioritizing availability, quality, and affordability, with an AI-driven, data-enabled capability for a predictive and resilient supply chain.

The transformation centers on two integrated pillars: an end-to-end planning and execution platform linking demand forecasting, manufacturing, inventory, and distribution across more than 25 international markets, and an 18-month overhaul of strategic sourcing and procurement with standardized processes, digital automation, and analytics-led decision-making.

Measurable impacts include a 75% reduction in drug stock-outs and up to 20% inventory optimization across the global distribution network, with improved coordination among commercial, manufacturing, and supply teams.

Mankind Pharma completed a multi-year global supply chain and strategic procurement overhaul in collaboration with Accenture to enhance medicine access, reliability, and scalable growth.

The changes deliver sustainable cost efficiencies while preserving quality, compliance, and supply continuity, reinforcing operational excellence and long-term resilience.

Analytics-led dashboards give leadership better visibility on spending, supplier performance, and risk, enabling sustainable cost efficiencies without compromising quality or compliance.

The transformation reinforces operational excellence and resilience while aligning with Mankind Pharma’s mission to deliver quality, affordable medicines, positioning the company to respond agilely to evolving health system needs and strengthen trust with patients, partners, and stakeholders in India and global markets.

The transformation supports disciplined execution and sustainable expansion as healthcare systems evolve in India and global markets.

The transformation strengthens operational resilience and enables faster, more reliable responses to evolving healthcare demands in India and beyond.

Accenture’s leadership highlighted the collaboration’s role in creating a predictive, resilient procurement ecosystem that supports scalable, compliant decision-making in a regulated environment.

The COO described the transformation as a digitally enabled, intelligent, and resilient value chain designed to ensure Availability, Quality, and Affordability of medicines, and to scale responsibly.

Context: Mankind Pharma is India’s fourth-largest pharma company with extensive manufacturing capacity, a large field force, and a diverse product portfolio, recently expanding with an acquisition to bolster women’s health leadership.